Literature DB >> 27512947

Patient-oncologist alliance and psychosocial well-being in Chinese society strongly affect cancer management adherence with cancer of unknown primary.

Yifei Ma1,2, Wei Xu1, Zhigao Liang3, Yiming Li4, Hongyu Yu2, Chunshan Yang5,6, Jidong Li7, Shuang Liang3, Tielong Liu1, Jianru Xiao1.   

Abstract

BACKGROUND: Patient-oncologist alliance and psychosocial well-being have strong associations with adherence to cancer management. For patients with cancer of unknown primary (CUP), adherence is crucial to treatment or occult primary screening plans. There has been no study investigating the relationship between alliance, psychosocial factors, and adherence in such patients or in Chinese sociocultural settings.
METHODS: The measures of alliance, psychosocial well-being, and adherence willingness were administered to patients with CUP, with a mean age of 58.33 ± 11.24 years. Multiple linear regression models were applied to investigate the independent relationship between alliance and adherence by controlling for socioeconomic and psychosocial confounders.
RESULTS: Alliance was found to be independently and positively associated with greater adherence willingness and adherence to treatment and follow-up screening after controlling for significant confounders, including medical conditions, psychosocial well-being variables, and socioeconomic factors.
CONCLUSION: Stronger patient-oncologist alliance may foster enhanced adherence to treatment and follow-up screening in patients with CUP. Patient-oncologist alliance seems affected by socioeconomic factors and psychosocial well-being in the Chinese sociocultural settings.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Chinese cultural settings; adherence; cancer of unknown primary; patient-oncologist alliance; psychosocial well-being

Mesh:

Year:  2016        PMID: 27512947     DOI: 10.1002/pon.4245

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  2 in total

1.  Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients.

Authors:  Yifei Ma; Wei Xu; Ruojing Bai; Yiming Li; Hongyu Yu; Chunshan Yang; Huazheng Shi; Jian Zhang; Jidong Li; Chenguang Wang; Jianru Xiao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-07       Impact factor: 9.236

2.  Stronger therapeutic alliance is associated with better quality of life among patients with advanced cancer.

Authors:  Teresa Thomas; Andrew Althouse; Lauren Sigler; Robert Arnold; Edward Chu; Douglas B White; Margaret Rosenzweig; Kenneth Smith; Thomas J Smith; Yael Schenker
Journal:  Psychooncology       Date:  2021-03-08       Impact factor: 3.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.